Cyp2a5 - cytochrome P450, family 2, subfamily a, polypeptide 5 Gene

Also Known as Coh; CYPIIA5; Cyp15a2

Species: Mus musculus

Gene Type: protein coding
Gene ID: 13087

Summary

Predicted to enable enzyme binding activity; heme binding activity; and monooxygenase activity. Acts upstream of or within cellular response to cadmium ion; heme metabolic process; and response to stilbenoid. Predicted to be located in cytoplasmic microtubule. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Is expressed in alimentary system; liver; nervous system; nose; and respiratory system. Human ortholog(s) of this gene implicated in nicotine dependence and warfarin resistance. Orthologous to human CYP2A13 (Cytochrome P450 family 2 subfamily A member 13) and CYP2A6 (Cytochrome P450 family 2 subfamily A member 6). [provided by Alliance of Genome Resources, Apr 2022]

Cyp2a5 Products (2)

mRNA Protein Name
NM_007812.4 NP_031838.2 cytochrome P450 2A5
NM_007812.4 NP_031838.2 cytochrome P450 2A5

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
acts upstream of or within cellular response to cadmium ion IDA
IDA: Inferred from direct assay
16183037 MGI
acts upstream of or within heme metabolic process IDA
IDA: Inferred from direct assay
16183037 MGI
involved in response to stilbenoid IEP
IEP: Inferred from expression pattern
17086191 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

cytochrome P450 2A5

  • coumarin 7-hydroxylase

  • cytochrome P450, 2a5

  • cytochrome P450-15-COH

  • cytochrome P450-IIA3.2

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-N0921 Dihydromethysticin 99.71% Unkown